The vertebrate adaptive immune system is capable of promoting cells to degranulate or phagocytose nearly any foreign pathogen by producing immunoglobulin G (IgG) proteins (antibodies) that recognize a specific region (epitope) of a pathogenic molecule (antigen). The ability to bind diverse antigens requires a diverse population of antibodies, which is achieved through complex processes in bone marrow and lymphatic tissues, namely V(D)J recombination and somatic hypermutation. The diversity of antibodies is astonishing; the size of the theoretical naive antibody repertoire is estimated to be >10 13 in humans 1 . In addition to their biological importance, antibodies are routinely used in biotechnology as probes and diagnostics, and dozens of antibodies have been approved as therapeutics 2 .
IntroDuctIon
The vertebrate adaptive immune system is capable of promoting cells to degranulate or phagocytose nearly any foreign pathogen by producing immunoglobulin G (IgG) proteins (antibodies) that recognize a specific region (epitope) of a pathogenic molecule (antigen). The ability to bind diverse antigens requires a diverse population of antibodies, which is achieved through complex processes in bone marrow and lymphatic tissues, namely V(D)J recombination and somatic hypermutation. The diversity of antibodies is astonishing; the size of the theoretical naive antibody repertoire is estimated to be >10 13 in humans 1 . In addition to their biological importance, antibodies are routinely used in biotechnology as probes and diagnostics, and dozens of antibodies have been approved as therapeutics 2 .
Next-generation sequencing techniques have enabled rapid determination of large numbers of antibody sequences 1 . A limitation of these approaches is that no information about the specific atomic contacts between the antibody and the antigen can be gleaned from these data sets. Atomic detail is required to consider specific antibody-antigen interactions, for example, in order to develop therapeutic antibodies or vaccines that are mimetics of extremely infectious antigens 3 . Although experimental methods capable of generating structural models in atomic detail (X-ray crystallography, NMR, neutron diffraction, cryo-electron microscopy (cryo-EM)) exist, not all protein structures can be determined with these methods, and limited resources make it impossible to determine the structures of all the sequences identified in high-throughput sequencing experiments. To bridge the sequence-structure gap, one must use computational structure prediction methods. Perhaps more importantly, structure prediction methods are useful in diagnostics and drug discovery to define epitopes and help infer biological or therapeutic mechanisms.
The function of an antibody arises from its 3D structure. The IgG isoform, the most common type of naturally occurring antibody, consists of two identical sets of heavy and light chains arranged in a 'Y' shape, with the four polypeptide chains joined by disulfide linkages. The heavy chain contains four domains, three adjacent constant domains (C H 1, C H 2, C H 3) and one variable domain (V H ), and the light chain consists of a single constant domain (C L ) and a variable domain (V L ). The C H 1 and V H domains interact with the C L and V L domains to form the antigen-binding fragment (F ab ) or the 'arms' of the Y. Within the F ab , both variable domains are directed away from the remaining heavy chain constant domains and make up the variable fragment (F V ). At the tip of the F V are three CDR loops on each chain (CDR L1-3 and CDR H1-3) that form the region of the antibody, called the paratope, that recognizes its target. This F V structure is common to other antibody isoforms (IgA, IgE and so on). modeled using template structures. Sequences that might not adopt canonical conformations, and may therefore yield inaccurate predictions, can be readily recognized by severe mismatches to the known patterns.
The remaining CDR loop, H3, does not adopt canonical conformations and must be modeled de novo. In addition, the H3 loop lies at the interface of the two domains (V H and V L ) and can interact with residues on either chain. To account for these interactions, as well as the overall geometry of the paratope, the V L -V H orientation is optimized during H3 modeling. Accurately modeling CDR H3 and the V L -V H orientation are typically the most challenging and critical aspects of antibody structure prediction [5] [6] [7] .
Protein-protein docking
Although accurate predictions of unbound antibody structures are informative, they are void of an important biological context: the antibody-antigen (Ab-Ag) interaction. High-resolution structures of Ab-Ag complexes give insight into the molecular mechanism by which antibodies function, a necessity for rational design of vaccines or antibody therapeutics. Structures of Ab-Ag complexes can be determined through experimental methods; however, just as with unbound antibodies, these methods are limited by their throughput and expense and are not viable for all proteins. When experimental methods cannot be used to determine complex structures, computational protein-protein interface prediction (docking) provides an alternative approach.
In general, computational docking approaches strive to sample all possible interactions between two proteins to discern the biologically relevant interaction. Predicting a protein-protein interaction de novo is challenging due to the sheer number of possible docked conformations. However, the sample space can be made tractable with information about the interaction. In the case of Ab-Ag interactions, the search space is limited because the antibody paratope, composed of the six CDR loops, is the binding site for the cognate antigen epitope.
The Rosetta SnugDock algorithm leverages the information about the flexible and/or uncertain regions of the antibody to perform robust Ab-Ag docking 8 . SnugDock simulates the induced-fit mechanism through simultaneous optimization of several degrees of freedom. It performs rigid-body docking of the multibody (V L -V H )-Ag complex, as well as remodeling of the CDR H2 and H3 loops, the latter of which typically contributes a plurality of atomic contacts to the Ab-Ag interaction 9, 10 . SnugDock can also simulate conformer selection by swapping either the antibody or the antigen with another member of a pregenerated structural ensemble. Because SnugDock samples most of the conformation space available to antibody paratopes, it can refine antibody homology models with inaccuracies in the difficult-to-predict V L -V H orientation and CDR H3 loop.
When docking homology models, it is best if there is experimental evidence to suggest the general location of the epitope (within ~8 Å), and in this article, we describe the local docking procedure in detail. If no information is available about the epitope, there are several programs that perform global docking or epitope prediction 11 . In particular, there are two fast-Fourier transform (FFT) rigid-body docking approaches that implement antibody-specific energy potentials: PIPER 12 with the antibody-ADARS potential 13 , and ZDOCK 14 with the antibody i-Patch potential 15 . FFT rigidbody approaches are fast, but they cannot account for antibody motions upon antigen binding or compensate for errors in the initial homology model; to our knowledge, SnugDock is the only flexible-backbone antibody docking method. It can provide a global-antigen docking alternative, but it is slower and, like others, can produce false-positive epitope predictions 8 . For local docking, SnugDock has been demonstrated to produce high-quality models when using an antibody homology model or crystal structure and the unbound antigen crystal structure as input 8 . In addition, SnugDock approaches used in the critical assessment of prediction of interactions (CAPRI) blind docking challenge 16 produced the best structure among all predictors for a flexible-loop target. SnugDock has been further assessed on a set of 15 antibodyprotein-antigen targets using CAPRI rankings ( Table 1) . CAPRI uses star-based rankings (*** = high quality, ** = medium, * = acceptable, 0 = incorrect) that consolidate three similarity metrics: ligand-RMSD (root mean square deviation), interface-RMSD and fraction of native contacts recovered (f nat ) 17 . Examining the highest attained CAPRI ranking among the ten lowest-energy docked models (starting with a homology-modeled antibody), SnugDock currently produces 2 high-quality, 11 medium-quality and 2 acceptable-quality models over 15 targets. These performance data have improved since the original SnugDock publication 8 because of updates in the energy function 18 and a switch to the kinematic loop closure (KIC) loop modeling method [19] [20] [21] . Although SnugDock has not been benchmarked and was not originally intended to be used on peptide or small-molecule antigens, there are no technical limitations to doing so; alternatively, FlexPepDock 22, 23 (peptides) or RosettaLigand 24 (small molecules) can be used to capture the degrees of freedom of those antigens, albeit without sampling the antibody degrees of freedom.
Experimental design: antibody homology modeling with RosettaAntibody (Steps 1-11) The protocol described here enables a user to generate a structural model of an antibody from its sequence and a structural model of an antibody-antigen complex from the structures of the antibody and its antigen (Fig. 1) . A detailed example of these steps, which can be run on a standard workstation, is supplied in the Supplementary Tutorial. Generating a structural model of an antibody from sequence in RosettaAntibody is done using homology modeling techniques; that is, segments from known structures with similar sequences are used. As described in detail below, the input sequence is split into several components. For each component, RosettaAntibody searches a curated database of known structures for the closest match by sequence and then assembles those structural segments into a model. That model is then used as the input for the next stage, in which the CDR H3 loop is modeled and the V L -V H orientation is optimized.
Numbering the residues in the sequence. The RosettaAntibody protocol identifies the CDRs of the input antibody sequence through regular expression matching to the Kabat CDR definition 25 , and it numbers the antibody residues according to the Chothia scheme 4 . sequence and orientation 27 . Starting from the list of all possible templates ordered by bit score, the best match is selected as the first template. To diversify the initial V L -V H orientations, all templates with V L -V H orientations (0.5 orientational coordinate distance (OCD), see Marze and Gray 27 ) similar to this template are pruned from the list. The best match remaining in the list is selected as the second template, and candidate templates similar to the second template are now removed from the list. This winnowing is repeated to create ten distinct templates. One grafted model will be created from each of these ten initial V L -V H orientations.
Grafting CDR templates.
Once the initial V L -V H orientations are set, the CDR templates are grafted onto each framework region by superimposing the two overlapping residues on either side of the loop with their corresponding residues on the framework regions. The graft points are then adjusted using cycles of minimization, random torsional sampling and cyclic coordinate descent 28, 29 of the two stem residues to prevent unphysical bond lengths and angles from being incorporated into the model. Finally, the sequence similarity using a BLAST-based method with custom databases constructed from high-quality structures in the PDB. As the CDR identity and length each constrain the possible canonical CDR conformations, we use separate databases for each loop-length combination. For example, 10-residue H1 loops, 11-residue H1 loops and 11-residue L1 loops are separate BLASTformatted databases. This ensures that a compatible canonical conformation is chosen for each CDR, although recently others have had success using loop templates of different lengths, particularly when somatic hypermutation introduces indels 26 .
The results for each structural component are sorted by BLAST bit score, and the sequence with the best score is selected as the template.
Initial V L -V H orientations.
The initial V L -V H orientation is selected as a template by BLAST in the same way as the other structural components; in this case, the entire F V sequence is used for the BLAST comparison. Unlike the other segments, ten V L -V H templates are selected to mitigate the weak correlation between , and an incorrect model meets the criterion (quality ≠ (high || medium || acceptable)). For the "Rigid-body" and "SnugDock" columns, the quality of the lowest-scoring model, by interface energy, is reported (an 'f' indicates a strong energy funnel, defined as five or more of the ten lowest-scoring models being medium quality or better). Ensemble SnugDock simulations were run with multitemplate grafting and a CDR H3 kink constraint. CAPRI Summary rows summarize model quality for all targets. CAPRI Summary Top 10 takes the highest-quality model from the ten lowest-scoring models.
structure is relaxed 30, 31 via iterations of side-chain optimization and gradient-based minimization while constraining the backbone and side-chain heavy atoms to find a native-like conformation at a local energy minimum in Rosetta's score function.
All-atom refinement of CDR H3 and the V L -V H orientation. The grafted models are crude and must be refined, particularly in the CDR H3 loop and the V L -V H orientation. The H3 loop is first completely remodeled in the context of the antibody framework using the next-generation KIC (NGK) loop modeling protocol 21 . For speed, the H3 loop side chains are each reduced to a single low-resolution pseudo-atom, and to ensure sampling of the C-terminal kink conformation 32 , atomic constraints are applied to the governing score function 33 . For subsequent high-resolution refinement, the all-atom CDR H3 side chains are recovered, all CDR side chains are repacked, and the CDR side chains and backbones are minimized. The V L and the V H domains are re-docked with a rigid-backbone RosettaDock protocol 34, 35 to remove any clashes created by the new H3 conformation, and the antibody side chains are again repacked. Using NGK, H3 is refined again in the context of the updated V L -V H orientation. The CDRs are packed and minimized again, and the model is saved as a candidate structure. The first grafted model is used as the starting point for 1,000 refined models, and the other grafted models are each used as the starting point for 200 refined models, for a total of 2,800 refined models. The models are sorted by Rosetta score, a proxy for the free energy, and thus low-scoring models indicate more favorable (better) energies. A subset of the low-scoring models can be selected (Box 1) as a set of final models or as an ensemble for docking or other downstream applications.
Experimental design: antibody-antigen docking with SnugDock (Steps 12-17)
Computational docking can be used to generate models of Ab-Ag complexes. In general, docking entails (i) roughly identifying (within 8 Å) the interacting interface through either experiments or global docking and (ii) refining the initial model through local docking. Below we describe local docking with SnugDock in detail.
Generating the starting model. SnugDock requires as an input a putative Ab-Ag complex that contains a reasonable interface 36 . The complex can be composed of single structures or sets of structures (ensembles, see Box 2). The interface defines the local search, between the antibody CDRs and the antigen. Initial models are often based on experimental results from, for example, mutagenesis or chemical cross-linking assays that identify interacting residues at the Ab-Ag interface. In the absence of experimental results, a global docking approach such as ZDOCK/ iPatch 15 or PIPER/ADARS 13 can generate putative complexes for refinement. Global docking can also be achieved with SnugDock, albeit at a higher computational expense. Antigen or antibody structures that have not been generated by a Rosetta protocol need to be refined before being placed in contact. Refinement, commonly referred to as the Relax protocol 30, 31 , entails iterations of side-chain optimization and gradient-based minimization in Rosetta's score function. The Relax protocol samples local conformational space around the starting structure to identify an energetic minimum in the score function. Through this process, Rosetta-identified nonidealities (such as van der Waals bumps) are abated. Once the partners have been refined (usually with the coordinates constrained to the starting position as in Nivón et al. 37 ), a putative complex can be assembled and prepacked. Prepacking optimizes side-chain conformations to prevent biasing toward the input complex model's side-chain conformations, ensuring uniform scoring of all potential bound complex states.
Performing docking. SnugDock iteratively performs multibody docking of both the Ab-Ag and V L -V H orientations, as well as remodeling of the H2 and H3 CDR loops. Before docking, the antigen in the prepacked Ab-Ag complex is subject to three rigidbody perturbations: (i) a randomized 'spin' around the Ab-Ag primary axis, uniformly sampled from 0 to 360°; (ii) a smallmagnitude random translation, with the magnitude sampled from a Gaussian distribution centered on 3 Å; and (iii) a smallmagnitude randomized 'tilt' in a random direction off the Ab-Ag primary axis, sampled from a Gaussian distribution centered on 8°. Docking operates in two phases: low-resolution mode, in which side chains are represented by a single pseudoatom located at the centroid of the side-chain heavy atoms, and high-resolution mode, in which all protein atoms are explicit. Low-resolution mode consists of two types of interspersed Monte Carlo moves: rigidbody Ab-Ag translation and rotation, and backbone ensemble conformer swaps. In addition, at the end of low-resolution mode, the H2 and H3 loops are refined. High-resolution mode consists of a 50-step Monte Carlo trajectory in which each move is selected from a set of five possible moves: rigid-body Ab-Ag docking (40%), rigid-body V L -V H docking (40%), CDR minimization (10%), H2 loop refinement (5%) and H3 loop refinement (5%), where the percentages indicate the probability of selecting each move. Each trajectory results in one model. Typically, SnugDock is used to generate a total of 1,000 models, with the low-scoring models most likely to be near the native conformation.
Box 1 | Assessment of antibody modeling and antibody-antigen docking results
The user must critically analyze computational models. To select high-quality models from a set produced by Rosetta, models should be evaluated for their energy, geometry, agreement with observations and diversity.
Model scores (energy)
Model structures output by Rosetta are ranked according to score, and typically we suggest using the ensemble of the ten lowest-scoring structures. Scores can be examined for individual models, or for the whole set of models, by plotting score versus RMSD (supplementary tutorial). In most simulations, ~90% of the models will span a total score range of 30-50 Rosetta energy units (REU) or an interface score range from 0 to -12 REU (Talaris2014 score function 18 ). Typically, ~1-5% of models will have scores ranging from within the bulk to 5-10 REU below the bulk, and the low scores (for either total or interface score) indicate that these are the models that Rosetta expects to be closest to the native structure. If the low-scoring models cluster in a single set within about a 1.0 Å RMSD from each other, Rosetta has converged upon a set of closely related models. Deeper-scoring wells and more densely populated wells provide higher confidence in the models. In simulations with multiple low-scoring structural clusters, each is similarly likely to be native-like.
Geometry
Assess the physical feasibility of the low-scoring models by eye in a molecular visualization package such as PyMOL. In rare cases, such as when template structures are unavailable, Rosetta may create obvious flaws such as polypeptide chain breaks or backbone clashes, particularly within the CDRs and at their graft points, so one should make a cursory examination of the model integrity. The accuracy of the non-H3 CDR loops can be assessed by comparing the CDR cluster of the grafted loop with the cluster of the input sequence, as identified by North et al. 53 (Step 5) . Likewise, the components of the V L -V H orientation can be checked to ensure that they lie within the observed natural distributions (Step 9); an exception to this rule can be made if the V L -V H orientation grafting templates and Rosetta sampling all lie far toward the edge of nature's distribution. For complex models, ensure that the lowest-scoring Ab-Ag models make good contacts between the antigen and the antibody paratope. Higher confidence can be assigned to complex models with large (~1,200 Å 2 ), complementary interfaces 35 , as well as those in which the H3 CDR loop makes several specific contacts. Any models discarded from the low-scoring set should be replaced with other low-scoring models.
agreement with observations
Ensure that the models are consistent with any experimental observations. For example, if experimental data show that a particular residue, when mutated, eliminates binding, then ensure that the paratope contacts at this site, unless there is evidence for allosteric effects. Again, replace any discarded models with other low-scoring models.
Diversity
It can be useful to seek a diverse set of candidate models-for example, to enhance conformational sampling during ensemble docking or when there is no single low-scoring cluster of models. Thus, the model set might be amended to include low-energy models from different structural clusters. Incorporating experimental data into the simulation. Two main types of experimental data that inform the Ab-Ag binding mode can be incorporated into SnugDock. First, knowledge about specific residues or pairs of residues that interact across the interface can be used to guide docking. This information could, for example, be derived from alanine scanning or other mutagenesis experiments, as has been successfully done 38 . Second, knowledge about the epitope and the overall Ab-Ag orientation can be incorporated. Complex structures have been successfully predicted using binding data derived from different experiments, including NMR hydrogen-deuterium exchange, NMR chemical shift perturbation, low-resolution cryo-EM and chemical cross-linking of the binding partners with subsequent analysis by mass spectrometry [39] [40] [41] .
Other methods for epitope mapping may also be suitable.
Depending on the type of experimental data available, there are different ways of incorporating it into the docking simulation. High-confidence residue-residue interactions can be preserved with the use of atom pair constraints. Less-specific and poorly characterized interactions (hydrophobic pockets, ambiguous H-bonds) can be loosely constrained with ambiguous and site constraints. Predicted epitopes and binding patches can be sampled by properly placing the SnugDock input structure and adjusting the size of the initial starting move. For further information on incorporating experimental constraints, see the Rosetta documentation (https://www.rosettacommons.org/docs/wiki/ rosetta_basics/Incorporating-Experimental-Data).
Caveats, challenges and pitfalls
There are several caveats associated with computational modeling of antibodies and docking of antibodies and antigens. Keeping these caveats in mind, the user should critically assess each prediction (Box 1). RosettaAntibody is a homology modeling approach and can be hampered by template availability. Challenging targets include heavily engineered antibodies, antibodies derived from a species that diversifies its antibodies through gene conversion, such as chickens or rabbits, or antibodies with flexible CDR H3 loops.
When templates exist, errors in the FR and CDR L1-3, H1 and H2 loops are typically small (no greater than a 1-Å backbone RMSD to native) 5 . In general, the V L -V H orientation is correctly captured by RosettaAntibody in 43 of 46 benchmark antibody targets 27 . On the other hand, the CDR H3 loop is modeled de novo, and loop model quality decreases with loop length. In the KIC loop benchmark 21, 42 , loops of 12-17 residues are modeled to near a 1-Å backbone RMSD relative to the native structure-the average human CDR H3 falls within that range, with an average length of 15 residues (under the international Immunogenetics (IMGT) database definition of CDR H3) 43 . However, the benchmark is measured by modeling loops on crystallographic frameworks, whereas in a blind context, CDR H3 loops are modeled on homology frameworks, which introduces uncertainty into the loop environment. Nevertheless, in a recent assessment 33 RosettaAntibody produced models with CDR H3 loops within a 1.59-Å backbone RMSD to native and sub-Ångstrom accuracy in all other regions.
RosettaAntibody models unbound, solution-state antibodies, and its predictions should be treated as such. In addition, each RosettaAntibody structure is implicitly treated as rigid, and the user should be less confident in a model of a CDR H3 known or expected to be flexible. Flexibility can be approximated by considering an ensemble of models in downstream protocols. The ensemble approach has the dual benefit of accounting for uncertainty in our homology models.
Conversely, SnugDock models the antigen-bound state of antibodies. 37% of CDR H3 loops exhibit a conformational change >1 Å upon antigen binding (this value is rarely >1 Å for the other CDR loops and the V L -V H orientation) 44 . To account for motions upon binding, as well as error introduced during antibody modeling, SnugDock samples alternative conformers from ensembles of antibodies and antigens, and it explicitly remodels the CDR H2 and H3 loops, docks the V L -V H chains and minimizes the interface. Thus, SnugDock emulates the lock-and-key, conformer selection and induced-fit binding models of the antibody. SnugDock does not, however, explicitly sample backbone degrees of freedom of the antigen or of the other canonical CDRs of the antibody. If the unbound and bound conformations differ substantially or if the homology models are poor, it could be difficult or impossible to model the docked complex accurately 45 . Despite this complication, SnugDock has successfully predicted Ab-Ag complexes from homology models 8 .
Comparable and alternative methods
Antibody modeling In addition to RosettaAntibody, there are three publicly accessible, fully automated web servers for antibody structure prediction: Kotai Antibody Builder 46,47 , Prediction of ImmunoGlobulin Structures (PIGS) 48 and ABodyBuilder 49 . The performance of each method was discussed in the recent Antibody Modeling Assessment (AMA) 6 , except for ABodyBuilder, which was developed and benchmarked on the AMA antibodies ex post facto. Although similar, these approaches differ in some underlying methods for CDR template selection and loop modeling, resources needed and best applications. For example, the Kotai
Box 2 | Increasing of sampling during docking by incorporating backbone structural ensembles
In Rosetta, an ensemble is a set of discrete conformations of a protein structure. SnugDock uses ensembles to approximate backbone conformational flexibility by sampling conformations from the ensemble during docking. Through this approach, not only does the protocol explore more conformational space than standard docking, but it can also compensate for model error-for example, by using an ensemble of models produced by a modeling approach such as RosettaAntibody in a previous step.
Rosetta ensembles can be converted directly from NMR ensembles, or they can be generated using any method that induces structural diversity, such as molecular dynamics or various Rosetta refinement protocols. The ensembles typically span small structural variations of 1-2-Å backbone RMSD 34 . We suggest using Rosetta's relax (unconstrained) 30, 31 and KIC [19] [20] [21] protocols to generate docking ensembles for antigens. In addition, RosettaAntibody creates ensembles of antibodies by default. More on generating and docking ensembles can be found in Chaudury and Gray 34 and in Rosetta's documentation (https://www.rosettacommons.org/docs/latest/Home). Antibody Builder relies more heavily on sequence-based rules for template selection and for CDR H3 base geometry. PIGS favors the selection of CDR and framework templates from a single source structure when possible. PIGS does not include backbone refinement, and thus it returns structures very rapidly with minimal computational cost. ABodyBuilder includes extensive refinement and has recent developments 49 ; it is different in that it allows CDR templates of mismatched lengths 26 and exploits a full 6D V L -V H determination strategy 7 . RosettaAntibody is unique in that its extensive conformational refinement focused on antibody degrees of freedom is designed and tested toward creating a structure that is at an energy minimum and appropriate for downstream applications, including docking or design.
Antibody-antigen docking. In addition to SnugDock, there are two freely available antibody docking approaches: PIPER 12 with the antibody-ADARS potential 13 and ZDOCK 14 with the Antibody i-Patch potential 15 . Both are rigid-body, FFT approaches that do not capture side-chain or backbone flexibility as SnugDock does and with key differences in the formulation of the energy potentials and in the docking algorithms. Thus, these methods should be used to explore global conformation space rapidly, whereas SnugDock should be used for thorough local refinement. The performance of ZDOCK with the Antibody i-Patch potential has been benchmarked on the same set of complexes as SnugDock. Thus, a direct comparison is possible with the current implementation of SnugDock, in which i-Patch produces complexes of CAPRI criteria 0.7 high-quality models/3.1 medium-quality models/7.0 acceptable-quality models (averaged >20 simulations, best in top 10) and SnugDock produces complexes with CAPRI criteria of 2 high-quality models/11 medium-quality models/2 acceptable-quality models (one simulation, best in top 10).
MaterIals

EQUIPMENT
Homology modeling data
Primary amino acid sequence of the variable domain of the light and heavy chains
Docking data
File of the antigen structure, formatted in Protein Data Bank (PDB) standard PDB-formatted file of the antibody structure or the homology modeling output, which consists of a single antibody with chains L and H  crItIcal Both of these can be single structures or an ensemble of structures. Software for running simulations via ROSIE web server Modern web browser RosettaAntibody and SnugDock can be run via a public web server (http://rosie.rosettacommons.org/), via Python bindings (PyRosetta, http://www.pyrosetta.org/) and through local installations of Rosetta. Rosetta is distributed as source code, and licenses are available from the RosettaCommons (http://www.rosettacommons.org/) free of charge for academic and nonprofit users. Rosetta can be installed on UNIX-like operating systems (including Mac OS X).
Hardware for running simulations manually (optional)
Workstation with multicore CPU(s) running a POSIX-compliant operating system (e.g., GNU/Linux, OS X) or a Linux-based cluster. Several public facilities are available. For example, the U.S. National Science Foundation provides clusters such as Stampede through the Extreme Science and In the first line above, replace '~' with the parent directory where you installed Rosetta on your machine. Similarly, be sure that the PATH variable includes the blastp program (e.g. export PATH=$PATH:/path/to/blastp where /path/ to/blastp is replaced with the directory containing the blastp executable). These path settings may be added to a configuration file such as .bashrc so that they are automatically set each time a terminal is opened (logged into).
2| Create a working directory and navigate to it:
mkdir/path/to/my_dir cd/path/to/my_dir 3| Obtain the amino acid sequences for the variable domain of your antibody (light chain and heavy chain) and save them in FASTA format (in your working directory) with the heavy and light chains noted in the comment lines, as follows:
DVVMTQTPLSLPVSLGNQASISCRSSQSLVHSNGNTYLHWYLQKPGQSPKLLIYKVSNRFSGVPDRFSG SGSGTDFTLKISRVEAEDLGVYFCSQSTHVPFTFGSGTKLEIKR
4| Use Rosetta's grafting application to find suitable templates, and graft them together to obtain a crude model of the antibody. Execute the application with the line below.
antibody.macosclangrelease\ -fasta antibody_chains.fasta | tee grafting.log
The application will output a directory called 'grafting' . The PDB-formatted files named model-0.relaxed.pdb, model-1.relaxed.pdb, …, model-9.relaxed.pdb will be your input for the H3 modeling. The ' | tee grafting.log' part of the command records all the program output in the file 'grafting.log' for later review. The '\' permits the command to be spread across multiple lines rather than just one.
? troublesHootInG 5| (Optional) Checking of grafted template structures (10-20 min) . Assign the CDR loops in your models to the CDR loop clusters described by North et al. 54 , using the same methodology as in Adolf-Bryfogle et al. 55 , and check whether the chosen templates are suitable. Run the cluster identification application as follows:
identify_cdr_clusters.macosclangrelease\ -s grafting/model-*.relaxed.pdb\ -out:file:score_only north_clusters.log North et al. clustered all CDR loop structures by their backbone dihedral angles and named them by CDR type, loop length and cluster size (e.g., 'H1-13-10' is the 10th most common conformation for 13-residue H1 loops). Occasionally, Rosetta chooses templates that are rare or inconsistent with the sequence preferences observed by North et al. For example, if Rosetta recommends the H1-13-10 cluster, the user might also consider the H1-13-1 cluster. Tables 3-7 of North et al. present consensus sequences for each cluster that can inform this decision.
Loops and clusters with proline residues are also worth a manual examination. Several clusters of North et al. are contingent on the presence of prolines in particular locations (e.g., L3-9-cis7-1 has a cis-proline at position 7). Because RosettaAntibody relies on BLAST to choose loop templates, occasionally a loop from an uncommon non-cis-proline cluster (e.g., L3-9-2) is chosen. In such cases, it is best to manually select a loop template from the well-populated cis-proline cluster.
6| (Optional) Rerun of grafting (3.5 h).
If desired, rerun grafting to replace a template with one from a manually specified source structure. Use the antibody command line as above with an extra flag to specify a template. 
7| H3 modeling (1 h-4 d).
Copy the set of standard H3 modeling flags to your working directory and create a directory for the H3 modeling output:
cp $ROSETTA/tools/antibody/abH3.flags.
mkdir H3_modeling
8|
Running of Rosetta's antibody_H3 application on the 10 models generated during grafting. This step requires 1,000 CPU hours and is often performed in parallel on a computer cluster (box 3). -nstruct specifies the number of structures generated, which should be 1,000 for model.0.pdb and 200 each for all other grafted models.
A numbering scheme can also be specific; see box 4. The expected output is the specified number of PDB files, as well as a score file named H3_modeling_scores.fasc. All these files will appear in an output directory named H3_modeling/.
To trivially run in parallel, simply repeatedly execute the above command (changing input models, number of structures and the output log as you wish). Each time the command is executed, an antibody_H3 process is run in the background.  crItIcal step Generating the 2,800 antibody structures takes ~2,500 CPU hours. If running 24 processes in parallel on a modern 24-CPU workstation, expect ~4 d of run time. Distributing the work over nodes on a supercomputer can reduce this time to hours (see MATERIALS). This script will create a subfolder (lhoc_analyis) with separate plots for each of the four antibody light-heavy orientational coordinate frame (LHOC) metrics. Figure 2 shows a representative plot of the heavy opening angle for two antibodies: one with a native-like distribution and another with a non-native distribution. Each plot shows the native distribution of V L -V H orientations (gray) and the orientations sampled by Rosetta (black line), as well as the top 10 models (labeled with diamonds) and the 10 different template structures generated during Step 4 (labeled with dots). Antibody models that are outside the native distributions are unlikely to be correct.
10| Choosing of final antibody models (10 min).
Choose ten of the antibody models as an ensemble for docking. The following criteria may be useful to consider, as docking with ensembles aims to increase conformational diversity and sampling: select models with the lowest total score-these are purportedly native-like; select models with natural V L -V H orientations falling within the observed distribution (gray); and select models derived from different templates to maintain diversity.
If all ten low-scoring models are outside the native distribution, consider returning to Step 6 and manually selecting new templates for the relative orientation of the V L and V H chains by using the -antibody:light_heavy_template flag (e.g., antibody.macosclangrelease -antibody:light_heavy_template 1ABC).
11| (Optional) Renumbering of antibody models (5 min).
Standard residue numbering facilitates comparison of different antibodies, but several different numbering schemes are used. RosettaAntibody uses the Chothia residue numbering scheme 4 by default, and other numbering schemes, such as enhanced Chothia 56 , AHo 57 , IMGT 58 and Kabat 59 , are specifiable with command options. To change residue numbering, we provide a conversion application. For example, to convert best_antibody.pdb from Chothia to AHo numbering, run the following command:
Box 3 | Use of Rosetta on different platforms and running in parallel
rosetta on different platforms Throughout this protocol, executables are suffixed by the platform and mode for which they were compiled (i.e., in antibody. macosclangrelease, 'macos' indicates that the antibody executable was compiled on a MacOS operating system, 'clang' indicates the Clang compiler was used, and 'release' indicates it was compiled in release mode). The suffix is highlighted in red throughout (.macosclangrelease). On other platforms you will replace this string with your operating system and compiler (for example, GNU/Linux platforms with gcc as the compiler will default to .linuxgccrelease). In addition, the suffix is prefixed by .mpi (.mpi.linuxgccrelease) when the executable is built for the message-passing interface (MPI) by an MPI compiler. MPI-compatible executables can communicate with one another for parallel processing, and some Rosetta executables use MPI nontrivially. However, most standard Rosetta applications are trivially parallelizable ('embarrassingly parallel') and thus capable of running on both MPI and non-MPI systems.
running in parallel
An example of how to locally run a non-MPI executable in parallel is given in Step 8. In general, add the -multiple_ processes_writing_to_one_directory flag to your command line, and then execute multiple instances of the process. This procedure works on a single desktop computer with multiple CPUs or remotely on a supercomputer cluster. However, running a Rosetta executable on a cluster strongly depends on the hardware configuration and available software (e.g., workload management software).
For example, to run a non-MPI executable via HTCondor, (i) save the standard command line as an executable bash script, (ii) write a submit description file specifying the executable bash script and the number of processes to execute and (iii) use the condor_submit command with the description file as an argument to submit your jobs to the cluster.
On the other hand, MPI executables can be run in parallel by prepending the command line with the mpirun -n XX command, where XX is the number of processes to run, if your machine is configured to use the Open MPI library. Again, the exact number depends on the specific hardware configuration. For example, to run an MPI executable on Stampede via the slurm workload manager, (i) save the standard command line as an executable bash script, (ii) write a slurm batch script specifying the executable bash script and the number of tasks and (iii) use the sbatch command with the bash script as an argument to submit your jobs to the cluster. 
antibody-antigen docking • tIMInG variable 12| Preparation of antibody and antigen for docking (1 h).
Prepare the antigen and antibody for docking. Format your antigen (and antibody, if you are not using a homology model produced by RosettaAntibody) PDB file so that it can be read by Rosetta. Run the following script:
$ROSETTA/tools/protein_tools/scripts/clean_pdb.py antigen.pdb C Where antigen.pdb is a PDB file of your antigen and C is the one-letter chain identifier(s) for the antigen chain(s) in the PDB file. (ii) Open the file using the text editor (e.g., Vim) and alter the chain IDs. First, navigate to the chain ID column. Next, engage blockwise visual mode (Ctrl-V), select the entire chain column for a specific ID (e.g., A) and delete it using the delete operator (d). Next, select the column, again using blockwise visual mode, and insert the new chain ID (shift+I, 'H', Esc). Repeat this process for each chain. antibody_ensemble.list is a text file that contains filenames with absolute paths to the ten antibody models selected after antibody modeling. In the case that you have a single crystal structure, you can omit the -ensemble1 flag.
If antigen flexibility is expected, a family of structures can be created with other Rosetta applications (box 2). The text file antigen_ensemble.list will contain the filenames of your antigen (using absolute paths). NMR starting structures must be split (i.e., each model should be in its own PDB file). To use a single antigen structure, omit the -ensemble2 flag.
17| Docking (1-15 h) . Dock the antibody to the antigen. As in Step 8, this is an expensive computational step and you have the option of running a single process, running multiple processes on one machine or splitting the job across processors on a supercomputer (box 3). Using the executable for an MPI-based computing cluster with 300 processes as an example, the command line for docking is as follows: • tIMInG Here we report the time to generate a single, docked model from antibody sequence and antigen crystal structure. Typically, however, thousands of models are generated, and thus we also indicate the timing for the full, recommended simulations. These time estimates were computed on a 2 × 2.4 GHz Quad-Core Intel Xeon processor; timing will vary for other computer configurations. 
antIcIpateD results
The antibody structure prediction and docking methods described in this article each produce a set of structural models that have been evaluated by a score function. In the case of antibody structure prediction, we have found through benchmarking and participation in the AMA that the accuracy of frameworks and non-H3 CDR loops can typically be expected to be within a 1.0-Å RMSD of the coordinates in a crystal structure. When the model deviates more than 1.0 Å in RMSD from crystallographic coordinates, it is usually because there is not a suitable known template in the PDB. These situations should become increasingly rare as more structures are deposited into the PDB, although heavily engineered antibodies should always be modeled with care. The H3 loop accuracy is variable and depends both on length and V L -V H orientation. Loop length is an important factor in the accuracy of de novo loop modeling methods because the search space increases exponentially with each additional residue in the loop. We expect accurate models of CDR H3 loops of length 14 or less 33 , but the lowest-scoring model may not be the most accurate. We therefore recommend using all ten models for downstream analysis. In AMA-II, we found that non-native V L -V H orientations can lead to explicit interactions between the light chain and the CDR H3 loop that are indistinguishable from native interactions 5 . The use of multiple V L -V H orientation templates 27 allows broader exploration of conformational space, sampling more low-scoring wells. Models generated from at least three different templates should be used to maximize the chance of capturing the native V L -V H orientation. Through benchmarking Ab-Ag docking, we have found that the accuracy of a complex model depends on the starting configuration of the partners and the accuracy of the models for each partner. SnugDock samples local conformation space, and thus a good starting structure (within 8 Å) generally results in sampling a near-native conformation. Equally important is the quality of the initial unbound models; near-native models enable increased docking performance (see table 1 : Bound-bound rigid body-docking versus unbound-unbound rigid-body docking). We have found that docking a homology-modeled antibody to the crystal structure of the unbound antigen typically results in at least one model of acceptable qualityin the ten low-scoring models (table 1).
